Joel Walbert on Nostr: WTF? 'This partnership will rely on Bio-Sourcing’s BioMilk platform, which uses ...

WTF?

'This partnership will rely on Bio-Sourcing’s BioMilk platform, which uses genome editing to produce monoclonal antibodies (mAbs) in transgenic goats’ milk. Currently, South Africa imports biotherapeutics, but Bio-Sourcing and Afrigen are planning a pilot program with hopes of later commercial-scale production of mAbs.'

https://www.genengnews.com/topics/bioprocessing/will-transgenic-goats-make-more-medicines-in-south-africa/